Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2024-06-03
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Its main objective is to evaluate the delay, in seconds, between the call being picked up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the event of a cardiac arrest, every minute counts. Studies have shown that the time between the patient's collapse and the start of ECM (External Cardiac Massage) is directly correlated to the survival rate after a cardiac arrest.
According to other studies, a maximum delay of 90 seconds between the call to the EMS and the recognition of the cardiac arrest would be the most optimal for the patient, but is it reached at the EMS 95? This study aims at evaluating the average time taken by the Assistants of Medical Regulation (ARM) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay.
Its main objective is to evaluate the delay, in seconds, between the call pick-up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95. This evaluation will be made in particular by determining the elements of language highlighting the cardiac arrest, those which lengthen the time of detection of the arrest and the delay of starting a procedure by the ARM. The study will be conducted within the EMS and will include a review of the current state of knowledge and experience of the MRAs. This study will be carried out within the EMS 95.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Time elapsed between the taking in charge of the call and the recognition of a cardiac arrest by the MRA
Prospective study within the EMS 95, to evaluate if the maximum delay of 90 seconds between the call to the EMS and the recognition of the cardiac arrest is reached.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Call involving cardiac arrest already identified as such by the caller or 18
* Call with criteria of proven death
* The caller does not speak French, the linguistic elements noted are not usable.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital NOVO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Ariane Zoya-Gillet
Role: PRINCIPAL_INVESTIGATOR
Hôpital NOVO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
EMS department - Hospital René Dubos - Pontoise
Pontoise, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dr Ariane Zoya-Gillet
Role: primary
Julie Narcisse
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRD2321
Identifier Type: -
Identifier Source: org_study_id